Posterior reversible encephalopathy syndrome in an HIV-infected patient on antiretroviral treatment: what is the risk factor?

Barbara Birner, Cédric Hirzel, Franca Wagner, Gabriel Waldegg

Open source

DOI
10.1136/bcr-2017-221998
Published
2018-01-04
Container
BMJ Case Reports
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bcr-2017-221998,
  title = {Posterior reversible encephalopathy syndrome in an HIV-infected patient on antiretroviral treatment: what is the risk factor?},
  author = {Barbara Birner and Cédric Hirzel and Franca Wagner and Gabriel Waldegg},
  year = {2018},
  journal = {BMJ Case Reports},
  doi = {10.1136/bcr-2017-221998},
  url = {https://doi.org/10.1136/bcr-2017-221998}
}

RIS

TY  - JOUR
TI  - Posterior reversible encephalopathy syndrome in an HIV-infected patient on antiretroviral treatment: what is the risk factor?
AU  - Barbara Birner
AU  - Cédric Hirzel
AU  - Franca Wagner
AU  - Gabriel Waldegg
PY  - 2018
JO  - BMJ Case Reports
DO  - 10.1136/bcr-2017-221998
UR  - https://doi.org/10.1136/bcr-2017-221998
ER  - 

APA

Birner, B., Hirzel, C., Wagner, F., & Waldegg, G. (2018). Posterior reversible encephalopathy syndrome in an HIV-infected patient on antiretroviral treatment: what is the risk factor?. BMJ Case Reports. https://doi.org/10.1136/bcr-2017-221998

Source records